Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ATAI |
---|---|---|
09:32 ET | 74676 | 1.6 |
09:34 ET | 12438 | 1.6077 |
09:36 ET | 15770 | 1.61 |
09:38 ET | 6142 | 1.609 |
09:39 ET | 470 | 1.61 |
09:41 ET | 30475 | 1.615 |
09:43 ET | 3440 | 1.615 |
09:45 ET | 700 | 1.61 |
09:48 ET | 4181 | 1.62 |
09:50 ET | 3784 | 1.615 |
09:52 ET | 10778 | 1.6199 |
09:54 ET | 7179 | 1.615 |
09:56 ET | 21181 | 1.605 |
09:57 ET | 1000 | 1.6098 |
09:59 ET | 8828 | 1.605 |
10:01 ET | 1100 | 1.605 |
10:03 ET | 4442 | 1.61 |
10:06 ET | 492 | 1.605 |
10:08 ET | 4034 | 1.6 |
10:10 ET | 9813 | 1.595 |
10:12 ET | 25840 | 1.585 |
10:14 ET | 16995 | 1.585 |
10:15 ET | 17754 | 1.595 |
10:17 ET | 799 | 1.6 |
10:19 ET | 239 | 1.605 |
10:21 ET | 14127 | 1.59 |
10:24 ET | 4488 | 1.605 |
10:26 ET | 16172 | 1.595 |
10:28 ET | 2000 | 1.595 |
10:30 ET | 205 | 1.595 |
10:32 ET | 1996 | 1.5995 |
10:33 ET | 2404 | 1.6 |
10:35 ET | 1900 | 1.59 |
10:37 ET | 11831 | 1.59 |
10:39 ET | 200 | 1.59 |
10:42 ET | 8296 | 1.59 |
10:44 ET | 5234 | 1.59 |
10:46 ET | 4611 | 1.585 |
10:48 ET | 5042 | 1.585 |
10:50 ET | 1563 | 1.58 |
10:51 ET | 12439 | 1.5808 |
10:53 ET | 6701 | 1.58 |
10:55 ET | 3077 | 1.58 |
10:57 ET | 641 | 1.58 |
11:00 ET | 400 | 1.58 |
11:02 ET | 1434 | 1.58 |
11:04 ET | 1400 | 1.58 |
11:08 ET | 2679 | 1.5889 |
11:09 ET | 22156 | 1.58 |
11:11 ET | 300 | 1.58 |
11:13 ET | 2480 | 1.585 |
11:15 ET | 2322 | 1.58 |
11:18 ET | 100 | 1.585 |
11:20 ET | 5890 | 1.575 |
11:22 ET | 20163 | 1.56 |
11:24 ET | 48309 | 1.57 |
11:26 ET | 6218 | 1.575 |
11:27 ET | 1333 | 1.575 |
11:29 ET | 100 | 1.575 |
11:31 ET | 100 | 1.579 |
11:33 ET | 100 | 1.575 |
11:36 ET | 1420 | 1.575 |
11:38 ET | 1350 | 1.57 |
11:40 ET | 4181 | 1.5694 |
11:42 ET | 2750 | 1.56 |
11:44 ET | 4415 | 1.5675 |
11:45 ET | 2500 | 1.56 |
11:47 ET | 8072 | 1.57 |
11:49 ET | 2032 | 1.565 |
11:51 ET | 245 | 1.5625 |
11:54 ET | 1132 | 1.56 |
11:56 ET | 7105 | 1.5615 |
11:58 ET | 6864 | 1.57 |
12:00 ET | 8349 | 1.575 |
12:02 ET | 348 | 1.5726 |
12:03 ET | 300 | 1.578 |
12:05 ET | 500 | 1.5799 |
12:07 ET | 3050 | 1.575 |
12:09 ET | 7432 | 1.565 |
12:12 ET | 515 | 1.565 |
12:14 ET | 1666 | 1.565 |
12:16 ET | 598 | 1.56 |
12:18 ET | 6298 | 1.56 |
12:20 ET | 350 | 1.565 |
12:21 ET | 5955 | 1.56 |
12:23 ET | 21283 | 1.555 |
12:25 ET | 73511 | 1.545 |
12:27 ET | 49418 | 1.54 |
12:30 ET | 5758 | 1.545 |
12:34 ET | 1000 | 1.5497 |
12:36 ET | 7214 | 1.545 |
12:38 ET | 3298 | 1.545 |
12:39 ET | 2220 | 1.545 |
12:41 ET | 1200 | 1.5477 |
12:43 ET | 788 | 1.54 |
12:45 ET | 400 | 1.54 |
12:48 ET | 300 | 1.54 |
12:50 ET | 750 | 1.545 |
12:52 ET | 7000 | 1.54 |
12:54 ET | 500 | 1.54 |
12:56 ET | 700 | 1.545 |
12:57 ET | 1201 | 1.54 |
12:59 ET | 1224 | 1.545 |
01:01 ET | 600 | 1.54 |
01:03 ET | 20641 | 1.555 |
01:06 ET | 1300 | 1.555 |
01:08 ET | 689 | 1.555 |
01:10 ET | 392 | 1.555 |
01:15 ET | 100 | 1.555 |
01:17 ET | 5814 | 1.555 |
01:19 ET | 3404 | 1.559 |
01:21 ET | 2151 | 1.5505 |
01:24 ET | 2312 | 1.55 |
01:26 ET | 668 | 1.56 |
01:28 ET | 5473 | 1.56 |
01:30 ET | 1000 | 1.55 |
01:32 ET | 2688 | 1.55 |
01:33 ET | 600 | 1.555 |
01:35 ET | 279 | 1.55 |
01:37 ET | 25260 | 1.558 |
01:39 ET | 400 | 1.55 |
01:42 ET | 2742 | 1.555 |
01:44 ET | 1600 | 1.555 |
01:48 ET | 2121 | 1.555 |
01:50 ET | 1500 | 1.56 |
01:51 ET | 16934 | 1.565 |
01:53 ET | 3609 | 1.565 |
01:55 ET | 100 | 1.565 |
01:57 ET | 1768 | 1.564 |
02:00 ET | 163 | 1.565 |
02:02 ET | 1000 | 1.5613 |
02:04 ET | 230 | 1.565 |
02:06 ET | 360 | 1.5682 |
02:08 ET | 1000 | 1.56 |
02:09 ET | 2000 | 1.565 |
02:11 ET | 500 | 1.565 |
02:13 ET | 740 | 1.565 |
02:18 ET | 11459 | 1.575 |
02:20 ET | 200 | 1.575 |
02:24 ET | 3500 | 1.575 |
02:26 ET | 26348 | 1.575 |
02:27 ET | 900 | 1.5753 |
02:29 ET | 3110 | 1.565 |
02:33 ET | 100 | 1.565 |
02:36 ET | 100 | 1.565 |
02:38 ET | 1600 | 1.565 |
02:40 ET | 1000 | 1.565 |
02:42 ET | 518 | 1.565 |
02:44 ET | 400 | 1.565 |
02:45 ET | 600 | 1.565 |
02:47 ET | 100 | 1.565 |
02:49 ET | 100 | 1.565 |
02:54 ET | 200 | 1.56 |
02:56 ET | 2722 | 1.555 |
02:58 ET | 22234 | 1.555 |
03:00 ET | 569 | 1.5552 |
03:05 ET | 7990 | 1.555 |
03:07 ET | 500 | 1.55 |
03:09 ET | 758 | 1.555 |
03:12 ET | 2352 | 1.555 |
03:14 ET | 1975 | 1.555 |
03:16 ET | 466 | 1.555 |
03:18 ET | 1765 | 1.555 |
03:20 ET | 1371 | 1.56 |
03:21 ET | 695 | 1.5554 |
03:23 ET | 1283 | 1.555 |
03:30 ET | 300 | 1.555 |
03:32 ET | 100 | 1.5599 |
03:34 ET | 400 | 1.555 |
03:38 ET | 9920 | 1.555 |
03:39 ET | 100 | 1.555 |
03:41 ET | 3697 | 1.555 |
03:43 ET | 1350 | 1.555 |
03:45 ET | 18406 | 1.555 |
03:48 ET | 24089 | 1.555 |
03:50 ET | 49057 | 1.56 |
03:52 ET | 30117 | 1.56 |
03:54 ET | 35643 | 1.5601 |
03:56 ET | 818 | 1.565 |
03:57 ET | 2087 | 1.565 |
03:59 ET | 3997 | 1.57 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
ATAI Life Sciences NV | 262.8M | -6.5x | --- |
Inovio Pharmaceuticals Inc | 262.5M | -1.8x | --- |
Candel Therapeutics Inc | 264.7M | -6.9x | --- |
Black Diamond Therapeutics Inc | 268.9M | -2.8x | --- |
Monte Rosa Therapeutics Inc | 250.7M | -1.6x | --- |
Rani Therapeutics Holdings Inc | 277.3M | -4.3x | --- |
ATAI Life Sciences NV is a Germany-based clinical-stage biopharmaceutical company. The Company engages in developing various treatments that focuses on various mental health disorders. The Company's therapeutic lead compound include PCN-101, a subcutaneous formulation of R-ketamine for the treatment of treatment-resistant depression (TRD); RL-007, a cholinergic, glutamatergic, and GABA-B receptor modulator to treat cognitive impairment associated with schizophrenia; DMX-1002, an oral formulation of ibogaine for treating opioid use disorder (OUD); GRX-917, an oral formulation of a deuterated version of etifoxine for the generalized anxiety disorder treatment; and NN-101, a novel intranasal formulation of N-acetylcysteine to treat mild traumatic brain injuries. Its therapeutic candidates also comprise VLS-01, a formulation of N,N-dimethyltryptamine for treating TRD; EMP-01, an oral formulation of an 3,4-methyl enedioxy methamphetamine for the treatment of post-traumatic stress disorder.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $262.8M |
---|---|
Revenue (TTM) | $277.0K |
Shares Outstanding | 167.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-0.24 |
Book Value | $1.46 |
P/E Ratio | -6.5x |
Price/Sales (TTM) | 948.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -42,344.04% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.